DNA synthesis inhibitors: Fluoroquinolones

17,671views

00:00 / 00:00

Videos

Notes

DNA synthesis inhibitors: Fluoroquinolones

Fam Med

Playlist

Antihistamines for allergies

Glucocorticoids

Coronary artery disease: Clinical (To be retired)

Heart failure: Clinical (To be retired)

Syncope: Clinical (To be retired)

Hypertension: Clinical (To be retired)

Hypercholesterolemia: Clinical (To be retired)

Peripheral vascular disease: Clinical (To be retired)

Leg ulcers: Clinical (To be retired)

Adrenergic antagonists: Alpha blockers

Adrenergic antagonists: Beta blockers

ACE inhibitors, ARBs and direct renin inhibitors

Thiazide and thiazide-like diuretics

Calcium channel blockers

Lipid-lowering medications: Statins

Lipid-lowering medications: Fibrates

Miscellaneous lipid-lowering medications

Antiplatelet medications

Hypersensitivity skin reactions: Clinical (To be retired)

Eczematous rashes: Clinical (To be retired)

Papulosquamous skin disorders: Clinical (To be retired)

Alopecia: Clinical (To be retired)

Hypopigmentation skin disorders: Clinical (To be retired)

Benign hyperpigmented skin lesions: Clinical (To be retired)

Skin cancer: Clinical (To be retired)

Diabetes mellitus: Clinical (To be retired)

Hyperthyroidism: Clinical (To be retired)

Hypothyroidism and thyroiditis: Clinical (To be retired)

Dizziness and vertigo: Clinical (To be retired)

Hyperthyroidism medications

Hypothyroidism medications

Insulins

Hypoglycemics: Insulin secretagogues

Miscellaneous hypoglycemics

Gastroesophageal reflux disease (GERD): Clinical (To be retired)

Peptic ulcers and stomach cancer: Clinical (To be retired)

Diarrhea: Clinical (To be retired)

Malabsorption: Clinical (To be retired)

Colorectal cancer: Clinical (To be retired)

Diverticular disease: Clinical (To be retired)

Anal conditions: Clinical (To be retired)

Cirrhosis: Clinical (To be retired)

Breast cancer: Clinical (To be retired)

Laxatives and cathartics

Antidiarrheals

Acid reducing medications

Anemia: Clinical (To be retired)

Anticoagulants: Warfarin

Anticoagulants: Direct factor inhibitors

Pneumonia: Clinical (To be retired)

Urinary tract infections: Clinical (To be retired)

Skin and soft tissue infections: Clinical (To be retired)

Protein synthesis inhibitors: Aminoglycosides

Antimetabolites: Sulfonamides and trimethoprim

Miscellaneous cell wall synthesis inhibitors

Protein synthesis inhibitors: Tetracyclines

Cell wall synthesis inhibitors: Penicillins

Miscellaneous protein synthesis inhibitors

Cell wall synthesis inhibitors: Cephalosporins

DNA synthesis inhibitors: Metronidazole

DNA synthesis inhibitors: Fluoroquinolones

Herpesvirus medications

Azoles

Echinocandins

Miscellaneous antifungal medications

Anti-mite and louse medications

Chronic kidney disease: Clinical (To be retired)

Kidney stones: Clinical (To be retired)

Urinary incontinence: Pathology review

PDE5 inhibitors

Stroke: Clinical (To be retired)

Lower back pain: Clinical (To be retired)

Headaches: Clinical (To be retired)

Migraine medications

Asthma: Clinical (To be retired)

Chronic obstructive pulmonary disease (COPD): Clinical (To be retired)

Lung cancer: Clinical (To be retired)

Bronchodilators: Beta 2-agonists and muscarinic antagonists

Bronchodilators: Leukotriene antagonists and methylxanthines

Pulmonary corticosteroids and mast cell inhibitors

Joint pain: Clinical (To be retired)

Rheumatoid arthritis: Clinical (To be retired)

Anatomy clinical correlates: Clavicle and shoulder

Anatomy clinical correlates: Arm, elbow and forearm

Anatomy clinical correlates: Wrist and hand

Anatomy clinical correlates: Median, ulnar and radial nerves

Anatomy clinical correlates: Bones, joints and muscles of the back

Acetaminophen (Paracetamol)

Non-steroidal anti-inflammatory drugs

Opioid agonists, mixed agonist-antagonists and partial agonists

Antigout medications

Osteoporosis medications

Pregnancy

Routine prenatal care: Clinical (To be retired)

Stages of labor

Breastfeeding

Amenorrhea: Clinical (To be retired)

Contraception: Clinical (To be retired)

Virilization: Clinical (To be retired)

Infertility: Clinical (To be retired)

Vulvovaginitis: Clinical (To be retired)

Sexually transmitted infections: Clinical (To be retired)

Menopause

Abnormal uterine bleeding: Clinical (To be retired)

Cervical cancer: Clinical (To be retired)

Estrogens and antiestrogens

Progestins and antiprogestins

Androgens and antiandrogens

Pediatric allergies: Clinical (To be retired)

Congenital heart defects: Clinical (To be retired)

Pediatric ear, nose, and throat conditions: Clinical (To be retired)

Pediatric constipation: Clinical (To be retired)

Pediatric gastrointestinal bleeding: Clinical (To be retired)

Pediatric vomiting: Clinical (To be retired)

Developmental milestones: Clinical (To be retired)

Puberty and Tanner staging

Precocious and delayed puberty: Clinical (To be retired)

Child abuse: Clinical (To be retired)

Vaccinations: Clinical (To be retired)

Pediatric infectious rashes: Clinical (To be retired)

Pediatric bone and joint infections: Clinical (To be retired)

Pediatric urological conditions: Clinical (To be retired)

Elimination disorders: Clinical (To be retired)

Neurodevelopmental disorders: Clinical (To be retired)

Pediatric ophthalmological conditions: Clinical (To be retired)

Pediatric upper airway conditions: Clinical (To be retired)

Pediatric lower airway conditions: Clinical (To be retired)

BRUE, ALTE, and SIDS: Clinical (To be retired)

Pediatric orthopedic conditions: Clinical (To be retired)

Mood disorders: Clinical (To be retired)

Anxiety disorders: Clinical (To be retired)

Eating disorders: Clinical (To be retired)

Obsessive compulsive disorders: Clinical (To be retired)

Personality disorders: Clinical (To be retired)

Sleep disorders: Clinical (To be retired)

Substance misuse and addiction: Clinical (To be retired)

Somatic symptom disorders: Clinical (To be retired)

Sexual dysfunctions: Clinical (To be retired)

Selective serotonin reuptake inhibitors

Serotonin and norepinephrine reuptake inhibitors

Tricyclic antidepressants

Monoamine oxidase inhibitors

Atypical antidepressants

Anticonvulsants and anxiolytics: Benzodiazepines

Psychomotor stimulants

Opioid antagonists

Assessments

DNA synthesis inhibitors: Fluoroquinolones

Flashcards

0 / 18 complete

Flashcards

DNA synthesis inhibitors: Fluoroquinolones

of complete

External References

First Aid

2022

2021

2020

2019

2018

2017

2016

Ciprofloxacin

for Crohn disease p. 391

cytochrome P-448 and p. 253

fluoroquinolones p. 192

mechanism (diagram) p. 184

meningococci p. 140

Mycobacterium avium- intracellulare p. , 193

prophylaxis p. 195

Pseudomonas aeruginosa p. , 141

Transcript

Content Reviewers

Yifan Xiao, MD

Contributors

Evan Debevec-McKenney

Our bodies consist of eukaryotic cells, while bacterias consist of prokaryotic cells.

So, in order to treat bacterial infections we can develop antimicrobials that only target prokaryotic cells while leaving our cells mostly unharmed.

One of these targets is bacterial DNA, and we call these medications DNA inhibitors or nucleic acid inhibitors.

There are plenty of processes and enzymes involved that we can target and the quinolones and fluoroquinolones inhibit an enzyme called DNA topoisomerase.

So there are many different types of topoisomerases but we’ll be looking at topoisomerase II, also called DNA gyrase, and topoisomerase IV.

Both types of topoisomerases cause double strand breaks in DNA, but at different points during mitosis.

Topoisomerase II plays a role in condensing the chromosomes by making a double strand break in the DNA so that it can be more tightly wound, causing a supercoil.

When enough supercoils are induced, the DNA condenses.

Topoisomerase IV plays a role later on, after the chromosome has been replicated, where it causes a double strand break in the DNA so the new DNA strand can be disentangled from the original.

Now, quinolones are created to target bacterial topoisomerases, but it was soon discovered that by adding a fluorine molecule to the quinolones, they become more effective.

So these newer medications, called fluoroquinolones, replaced the older quinolones in most clinical settings.

Common fluoroquinolones include ciprofloxacin, ofloxacin, balofloxacin, levofloxacin, gemifloxacin, and moxifloxacin.

One way to tell a fluoroquinolone apart from other antimicrobials is that they all have the suffix “-floxacin.”

These medications can be taken peroral or via IV, but ciprofloxacin and ofloxacin are also available in otic formulations, while moxifloxacin is also available in ophthalmic solutions.

Now fluoroquinolones are broad spectrum bactericidal antibiotics and ciprofloxacin in particular is widely used.

They are very effective against gram negative bacterias like Enterobacteriaceae, Haemophilus, Legionella, Neisseria, Moraxella, and even Pseudomonas species.

Elsevier

Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX